Phlegmasia cerulea dolens with venous-induced arterial inflow compromise successfully treated by single-session pharmacomechanical thrombectomy: A case report Authors: Marwan Aljohani, Mohammed Al Ali, Abdulkader Alkenawi, Azzam Khankan Published: 2026 ABSTRACT AbstractPhlegmasia cerulea dolens (PCD) is a rare but catastrophic manifestation of venous thromboembolism characterized by near-complete iliofemoral venous occlusion, severe venous hypertension, and secondary arterial inflow compromise. Delayed intervention is associated with venous gangrene, limb loss, and high mortality rates. A 76-year-old male with active rectal malignancy on chemotherapy presented with acute left lower limb pain, swelling, coldness, and cyanosis. CT run-off demonstrated extensive iliofemoral deep venous thrombosis extending from the inferior vena cava (IVC) bifurcation to the infrapopliteal veins, accompanied by loss of distal arterial opacification without intrinsic arterial occlusion—findings diagnostic of advanced PCD with venous-induced arterial inflow collapse. The patient underwent urgent single-session pharmacomechanical thrombectomy using large-bore aspiration with adjunctive low-dose intraprocedural tissue plasminogen activator (tPA) boluses, without catheter-directed thrombolytic infusion. Rapid venous decompression resulted in immediate clinical and hemodynamic improvement, restoration of arterial Doppler signals, and limb salvage. Post-procedural follow-up confirmed sustained limb viability and complete clinical resolution of venous congestion without evidence of recurrent thrombosis. Single-session pharmacomechanical thrombectomy with limited intraprocedural thrombolytic dosing is an effective, limb-saving strategy for advanced PCD, particularly in high-risk oncologic patients.Keywords: Phlegmasia cerulea dolens, Pharmacomechanical thrombectomy, Deep vein thrombosis, Venous gangrene, Limb salvage Introduction Phlegmasia cerulea dolens represents the most severe end of the deep venous thrombosis (DVT) spectrum and represents a life- and limb-threatening vascular emergency. The condition results from near-total occlusion of the iliofemoral venous system with failure of collateral drainage, leading to extreme venous hypertension, massive limb edema, microvascular collapse, and secondary arterial inflow compromise despite anatomically patent arteries [[1], [2], [3], [4]]. If untreated, this pathophysiologic cascade may rapidly progress to venous gangrene, compartment syndrome, limb loss, systemic shock, and death, with reported mortality rates approaching 25%-40% [2,3]. Contemporary evidence and guideline recommendations emphasize that anticoagulation alone is insufficient in advanced PCD [6,7]. While catheter-directed thrombolysis (CDT) has historically been employed, its limitations—including bleeding risk, prolonged treatment duration, and delayed venous decompression—have led to increasing adoption of mechanical and pharmacomechanical thrombectomy techniques [[8], [9], [10], [11]]. These approaches allow rapid, single-session restoration of venous outflow while minimizing thrombolytic exposure, a critical consideration in elderly and oncologic patients. Case history Clinical presentation A 76-year-old man with diabetes mellitus, hypertension, and rectal adenocarcinoma on active chemotherapy and prolonged immobilization presented with a 1-hour history of rapidly progressive left lower limb pain, swelling, coldness, and bluish discoloration. He reported worsening paresthesia and inability to bear weight. There was no recent surgery, trauma or known thrombophilia. On examination, the left lower limb was markedly tense and edematous from thigh to foot, with diffuse cyanosis and mottling. Sensation was diminished reflecting muscle ischemi distally. Distal pulses were not palpable, and Doppler interrogation revealed a weak monophasic posterior tibial signal. The patient was tachycardic and borderline hypotensive but afebrile. These findings were highly concerning for advanced PCD with threatened limb viability [1,2]. Laboratory findings Initial laboratory evaluation revealed markedly elevated serum lactate (9.3 mmol/L; reference range: 0.5-2.0 mmol/L) with metabolic acidosis (pH 7.28; reference: 7.35-7.45; bicarbonate 18 mmol/L; reference: 22-28 mmol/L), supporting severe limb hypoperfusion secondary to venous outflow obstruction. Complete blood count demonstrated anemia (hemoglobin 8.0 g/dL; reference: 13-17 g/dL) and mild leukocytosis (13.0 × 10⁹/L; reference: 4-10 × 10⁹/L). Creatine kinase was elevated (1245 U/L; reference: 20-200 U/L), suggestive of early muscle ischemia related to sustained venous hypertension. Coagulation studies showed mild prolongation of prothrombin time (PT 20 seconds; reference: 11-13.5 seconds; INR 1.7; reference: 0.8-1.2), consistent with systemic stress. Following urgent venous decompression and resuscitation, lactate levels decreased to 1.6 mmol/L within 2 hours, correlating with rapid clinical improvement [3]. Imaging findings In terms of CT Run-Off of the Lower Limbs, in arterial phase, marked attenuation and complete absence of contrast opacification were noted within the popliteal and infrapopliteal arteries, with progressive diminution of contrast in the distal superficial femoral artery. No arterial embolus, dissection, or flow-limiting atherosclerotic lesion was identified. In venous phase, extensive thrombosis involved the left common iliac, external iliac, common femoral, femoral, popliteal, and infrapopliteal veins, extending cranially to the IVC bifurcation, with associated severe soft-tissue edema. Interpretation The combination of complete iliofemoral venous occlusion on venous-phase imaging and absent distal arterial opacification on arterial-phase imaging without evidence of arterial thrombus or flow-limiting stenosis is characteristic of advanced phlegmasia cerulea dolens with venous-induced arterial inflow compromise. Severe venous hypertension from extensive thrombosis results in microvascular collapse and secondary reduction in arterial inflow, mimicking acute arterial ischemia despite anatomically patent arteries. When integrated with clinical findings of cyanosis, tense edema, and severe pain, these imaging features confirm the diagnosis and mandate urgent venous decompression rather than arterial intervention [4,5,12]. Endovascular Management: Given the limb-threatening presentation, the patient was transferred emergently to the Interventional Radiology suite. Access and Diagnostic Venography: Right internal jugular venous access was obtained, and a 10-French vascular sheath was placed. Diagnostic venography confirmed complete occlusion of the left common and external iliac veins with absence of antegrade flow into the femoral and popliteal venous segments. Single-session pharmacomechanical thrombectomy Single-session pharmacomechanical thrombectomy was performed using a stepwise aspiration strategy with the Penumbra Lightning system. Following venous access, a bolus of 10,000 IU of unfractionated heparin was administered intravenously. Aspiration thrombectomy was initially undertaken using a medium-caliber aspiration catheter (Penumbra Lightning 8), achieving partial thrombus debulking within the thrombosed iliofemoral venous system. Interval venography demonstrated persistent thrombus burden, prompting escalation to large-bore aspiration with a Penumbra Lightning 12 catheter, which resulted in substantial thrombus clearance. Adjunctive lysis-assisted therapy was performed using selective intraprocedural bolus administration of tissue plasminogen activator (total dose 14 mg) within the femoral, popliteal, and iliac venous segments. No prolonged catheter-directed thrombolytic infusion was used. Final venography confirmed restoration of normal antegrade venous outflow from the femoral vein through the iliac veins into the inferior vena cava. Given the patient’s active malignancy and associated hypercoagulable state, a temporary retrievable infrarenal inferior vena cava filter was placed for pulmonary embolism prophylaxis [9,13]. Outcome and follow-up Within 2 hours of the procedure, limb cyanosis resolved, capillary refill normalized, pain significantly improved, and arterial Doppler signals became biphasic. Limb edema decreased substantially, and hemodynamic stability was restored. The patient was managed post-procedurally with therapeutic anticoagulation and transitioned to oral anticoagulation (Fig. 1, Fig. 2, Fig. 3, Fig. 4, Fig. 5). Clinical photographs on presentation demonstrating profound edema, mottling, and violaceous discoloration of the left lower extremity, reflecting severe venous congestion and threatened limb viability in phlegmasia cerulea dolens. (A) Sagittal arterial-phase CTA demonstrates markedly reduced distal arterial opacification with absent arterial-phase filling of the popliteal and infrapopliteal arteries. (B) Sagittal delayed (venous-phase) CTA shows delayed opacification of the popliteal artery with moderate non-calcific stenosis apparent on late images, consistent with sluggish arterial inflow. (C) Coronal venous-phase CTA demonstrates extensive iliofemoral and ilio-caval venous thrombosis associated with severe soft-tissue edema of the left lower limb. Venography shows complete blockage of the left iliofemoral veins at the left common iliac vein, with no forward flow, indicating severe acute deep vein thrombosis and significant venous outflow obstruction. (A, B) Diagnostic venography shows acute thrombotic occlusion in the left common iliac vein with the thrombectomy catheter in place. (C, D) Post-thrombectomy venography confirms restored patency and rapid antegrade flow. Clinical photograph of the lower limbs after urgent pharmacomechanical thrombectomy for phlegmasia cerulea dolens shows resolved cyanosis, improved skin color, reduced edema, and no signs of venous gangrene or skin necrosis, indicating effective venous decompression. Discussion Modern understanding of PCD emphasizes that limb ischemia arises from extreme venous hypertension rather than primary arterial obstruction [1,4]. Prompt restoration of venous outflow reverses microvascular collapse and restores arterial inflow, as demonstrated in this case. In advanced phlegmasia cerulea dolens, rapidly progressive limb pain, swelling, and cyanosis—despite preserved limb warmth—combined with arterial-phase CT findings may mimic acute arterial occlusion; recognition of venous thrombosis is essential to guide urgent venous decompression. Over the past decade, evidence has increasingly supported early thrombus removal strategies in patients with advanced iliofemoral DVT and phlegmasia [[6], [7], [8], [9]]. While CDT remains effective, randomized trials such as ATTRACT and CaVenT have highlighted its bleeding risk and limited benefit in selected populations [7,8]. Consequently, current guidelines from the Society of Interventional Radiology and European Society for Vascular Surgery endorse mechanical or pharmacomechanical thrombectomy in patients with limb-threatening presentations [9,15]. Single-session pharmacomechanical thrombectomy with adjunctive low-dose intraprocedural tPA allows rapid venous decompression while minimizing thrombolytic exposure, making it particularly suitable for elderly and oncologic patients [10,11,14]. This strategy aligns with contemporary device-era practice and was instrumental in achieving limb salvage in the present case. Conclusion Advanced phlegmasia cerulea dolens is a vascular emergency requiring immediate recognition and prompt venous intervention. Single-session pharmacomechanical thrombectomy with limited intraprocedural thrombolytic dosing is a safe and highly effective limb-saving strategy. CT evidence of arterial inflow collapse in the setting of extensive venous thrombosis should prompt urgent venous decompression to prevent venous gangrene and limb loss. Ethics approval and consent to participate Ethical approval was not required for this study in accordance with institutional policy, as this is a single case report. Availability of data and materials All data generated or analyzed during this study are included in this published article. Author contributions MA conceived the study, performed the intervention, and drafted the manuscript. All authors contributed to data interpretation, critical revision of the manuscript, and approved the final version. Patient consent Written informed consent was obtained from the patient for publication of this case report and any accompanying images. Footnotes Acknowledgments: The authors received no specific funding for this work. Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. References Associated Data Data Availability Statement All data generated or analyzed during this study are included in this published article.